Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 24-02-2009 |
Symbol | ATSG2 |
Location | 5q33.1 |
Name | atelosteogenesis, type II |
Other name(s) | neonatal osseous dysplasia I (De La Chapelle type) |
Corresponding gene | SLC26A2 |
Other symbol(s) | AO2, DLCD |
Main clinical features |
|
Genetic determination | autosomal recessive |
Related entries | Mc Alister dysplasia |
Function/system disorder | osteo-articular |
Type | disease |
Gene product |
Name | sulfate transporter (SLC26A2) |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
| various types
|  
|  
| homozygous aminoacid substitutions within extracellular loops or the N or C terminus or compound heterozygosity for a truncating and a mild mutation
| various types
|  
| truncated protein
| a R279W substitution, a deletion of C418 predicting a frameshift and a premature stop codon (leading to reduced mRNA levels)
| |
Remark(s) |
Genotype/Phenotype correlations | compound heterozygote for the recurrent (p.R279W) and (p.G663R) mutations; G663R localized within the cytoplasm, and not to the cell membrane, suggesting loss-of-function mutation, leading to intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia |